Source:http://linkedlifedata.com/resource/pubmed/id/12824538
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2003-6-25
|
pubmed:abstractText |
Although MDM2, the product of mouse double minute-2 (mdm2) gene, or its human homologue possesses the potential to confer tumorigenic properties, it induces G1/S arrest in nontransformed cells. Flow cytometry provides a way to determine the effects of MDM2 on the cell cycle by expressing the protein ectopically, immunostaining cells expressing MDM2 and analyzing their DNA content. The DNA histograms of MDM2-transfected and untransfected cells can then be used to visualize the effect of ectopically expressed MDM2 on the cell cycle. Fluorescence-activated cell sorter (FACS) analysis following bromodeoxyuridine (BrdU) incorporation can be used to determine whether MDM2-expressing cells are synthesizing DNA. Incorporation of BrdU during DNA synthesis or repair can be detected in partially denatured DNA with a BrdU-specific fluorescent antibody. Subsequent staining of transfected MDM2 with a different fluorochrome provides information about whether transfected cells make significant progression through S phase. Further analysis of the growth-regulatory properties of MDM2 will elucidate both its normal function and the ways in which its deregulation leads to tumorigenesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites,
http://linkedlifedata.com/resource/pubmed/chemical/Bromodeoxyuridine,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/MDM2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mdm2 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-mdm2
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1064-3745
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
234
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-67
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12824538-Animals,
pubmed-meshheading:12824538-Antimetabolites,
pubmed-meshheading:12824538-Bromodeoxyuridine,
pubmed-meshheading:12824538-Cell Cycle,
pubmed-meshheading:12824538-Cell Separation,
pubmed-meshheading:12824538-DNA,
pubmed-meshheading:12824538-Flow Cytometry,
pubmed-meshheading:12824538-Growth Inhibitors,
pubmed-meshheading:12824538-Humans,
pubmed-meshheading:12824538-Mice,
pubmed-meshheading:12824538-Nuclear Proteins,
pubmed-meshheading:12824538-Proto-Oncogene Proteins,
pubmed-meshheading:12824538-Proto-Oncogene Proteins c-mdm2
|
pubmed:year |
2003
|
pubmed:articleTitle |
Flow cytometric analysis of MDM2-mediated growth arrest.
|
pubmed:affiliation |
Department of Biochemistry, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|